LGVN - Why Longeveron Stock Skyrockted 661.2% in November
Shares of Longeveron (NASDAQ: LGVN) jumped 661.2% in November, according to data from S&P Global Market Intelligence . The stock surged after it was announced that the company received a Rare Pediatric Disease (RPD) designation for its Lomecel-B treatment.
For further details see:
Why Longeveron Stock Skyrockted 661.2% in November